Rights issue 2022

S2Medical - Application form for exercise of warrants (TO1 B)
(This subscription note must only be used by directly registered shareholders in accordance with the instructions in the press release)

S2Medical - Application without preferential rights

Prospectus (SWE)

Terms and conditions for the warrants of series TO1

2022-03-15: Notice to attend the general meeting of S2Medical AB (publ)

2022-03-15: S2Medical AB (publ) resolves on a rights issue of units of approximately 30,1 MSEK guaranteed up to 70 percent

The Board's decision on the rights issue

Resolution on amendment of the Articles of Association

Stock Market

More about S2Medical AB (publ)

S2Medical is an innovative medical technology company founded in 2013 with headquarters in Linköping. S2Medical develops and sells wound healing products with a focus on burns and chronic wounds. The company has developed eiratex®, a new cellulose-based material for healing both burns and chronic wounds. eiratex® is produced in its own production facility in Linköping and heals wounds efficiently, often completely without the need for a dressing change. As the need for dressing changes is virtually eliminated, the dressing both means an increased quality of life for the patient and can lead to large cost savings for healthcare. With the help of the material eiratex®, obstacles to an establishment in the form of ethical and religious contradictions that exist in relation to current methods of using animal and human skin are also avoided.